secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagonist Therapeutics, Inc (PTGX)
CIK:        0001377121
Form:       8-K
Filed at:   2023-04-10T23:59:59+00:00
Accession:  0001104659-23-043353
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagonist Therapeutics announces $100M public offering of 5M shares at $20/share
--------------------------------------------------------------------------------

- 5,000,000 shares offered at $20.00 each; underwriters have 30-day option for 750,000 additional shares.
- Gross proceeds expected ~$100M before underwriting discounts and expenses, closing April 10, 2023.
- Underwriting syndicate led by J.P. Morgan, Jefferies, and Piper Sandler & Co.
- Shares offered under effective shelf registration statement No. 333-266595.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1377121/000110465923043353/0001104659-23-043353-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1377121/000110465923043353/tm2311339d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-043353

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer